NEU 4.15% $13.61 neuren pharmaceuticals limited

Share Price, page-4950

  1. 2,037 Posts.
    lightbulb Created with Sketch. 484
    Is it possible therefore, that the pricing may have reduced the interest in ROW rights, rather than increase it, because even at a viable discount the price would be too high to sway regulators to subsidize it?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.